An Open-Label, Randomized, Multi-Center, Phase III Study

  • Jha, Gautam (PI)
  • Dudek, Arkadiusz Z (Prior Principal Investigator)

Project: Research project

Project Details

Description

An Open-Label, Randomized, Multi-Center, Phase III Study to Compare the Safety and Efficacy of TKI258 vs Sorafenib in Patients with Metastatic Renal Cell Carcinoma after Failure on Anti-Angiogenic (VEGFtargeted and mTOR inhibitor) Therapies
StatusFinished
Effective start/end date8/1/118/30/15

Funding

  • Novartis Pharma AG

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.